הקסקסים - Hexaxim

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	J07CA Bacterial and viral vaccines, combined
××¨××× ×¤×¢×× (ATC5)	Â Diphtheria toxoid âJ07CA09 Filamentous haemogglutinin (fha) 25 MCG / 0.5 ML âJ07CA09 Haemophilus influenzae type b polysaccharide 12 MCG / 0.5 ML âJ07CA09 Hepatitis b vaccines 10 MCG / 0.5 ML âJ07CA09 Pertussis toxoid (pt) 25 MCG / 0.5 ML âJ07CA09 Poliovirus type 1 inactivated 40 DU / 0.5 ML âJ07CA09 Poliovirus type 2 inactivated 8 DU / 0.5 ML âJ07CA09 Poliovirus type 3 inactivated 32 DU / 0.5 ML âJ07CA09 Tetanus protein conjugate 22 - 36 MCG / 0.5 ML âJ07CA09 Tetanus toxoid âJ07CA09
×¦××¨×ª ××ª×	×ª××-×©×¨××¨× - I.M
×¦××¨×ª ××× ××	×ª×¨×××£ ××××¨×§×, SUSPENSION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Hexaxim (DTaP-IPV-HB-Hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenza type b (Hib).The use of this vaccine should be in accordance with official recommendations.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××§×¡×§×¡×× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	SANOFI PASTEUR, FRANCE
×©× ××¢× ××¨××©××	MEDICI MEDICAL LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 2/2017. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	19/12/2021

השינוי האחרון נעשה בֹ־19 בינואר 2025 ב־17:36